Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
BlackSky Technology heads into November earnings with an uncomfortable backdrop: the CEO has been selling, short interest remains near 20% of the float, and Jefferies turned cautious just four months ago.
The insider story is the sharpest signal here. On September 11, CEO Brian O'Toole sold 56,280 shares at $20.95, netting just over $1.1 million. That sale was not covered by a 10b5-1 pre-arranged plan, making it a discretionary trade. CFO Henry Dubois sold 15,225 shares the same day, also outside a plan. General Counsel Christiana Lin added 13,052 shares to her September 11 sales, then returned on September 21 alongside O'Toole and Dubois for a second round, this time under 10b5-1 plans. Net insider selling over the past 90 days totals roughly 138,500 shares, worth approximately $2.99 million. The September 11 cluster, discretionary and across three officers simultaneously, stands out as the more significant signal.
Short positioning tells a consistent story. Short interest has held remarkably stable around 19.8% to 20% of the free float for the past six weeks, with no material change over the month. That is a high absolute level, and the FINRA fortnightly figure of 6.94 million shares with a days-to-cover of 7.1 reinforces how entrenched the short base is. Yet the borrow market is not particularly tight: availability has actually loosened over the past week to 147%, meaning there are roughly 14.8 million shares available to borrow against 7.1 million already shorted, so there is no mechanical squeeze pressure building right now. Cost to borrow has ticked up about 12% on the week to 0.58%, but at that level it remains cheap. Options positioning has nudged slightly more defensive, with the put/call ratio at 0.30, modestly above its 20-day average of 0.29, and sitting about 1.7 standard deviations above the mean. That is cautious but not alarmed.
The Street is split but has tilted toward caution. Jefferies downgraded from Buy to Hold in June and set a $50 target, a figure that looks stretched against a $21.85 stock. Canaccord Genuity and HC Wainwright both maintain Buy ratings with targets in the $26 to $42 range. The mean price target of around $39 implies substantial upside from current levels, but the bear case is hard to dismiss. BlackSky missed Q2 revenue badly, printing $22.2 million against a $27.5 million consensus, and then cut full-year guidance to $105 to $130 million from $120 to $145 million. EBITDA estimates were slashed from $16 million to $6.9 million. The EV/EBITDA multiple has compressed about 10% over the past 30 days to 23x, reflecting that repricing. An EPS surprise factor score of 91 looks incongruous against that recent miss, suggesting the longer track record has been stronger even if the most recent print disappointed.
Ownership carries one particularly noteworthy element. Mithril LP holds a Schedule 13D activist position, the most recently amended filing dated August 20, 2026. A 13D signals an intent to influence the company, not merely hold it. The previous disclosed stake was 6.6%, though the current percentage is not confirmed in the latest amendment. As always with 13D/G filings, the stake is as-last-disclosed around the 5% threshold, and Mithril could have moved without a further filing. BlackRock has been adding, reporting 7.6% of shares held as of September 30, up from a prior 6.5% disclosure, making it the largest institutional holder. Tema ETFs and Tidal Investments both built near-full positions over the last quarter, pointing to some ETF-driven inflows. Thales, the French defence group, holds 4.5% and has not changed its position.
The ORTEX short score of 72.7 places the stock firmly in elevated-pressure territory, though it has eased marginally from a recent peak near 73.4 earlier in the week. Peers have had a mixed week: PL gained 8.3% over the past seven days while SPIR fell 4.9%, pointing to uneven sentiment across the small-cap geospatial cluster rather than a uniform directional move.
With earnings due November 6, the question is whether management can narrow the gap between guidance and its own prior ambitions, and whether the CEO's discretionary selling ahead of that date reflects what he knows about the quarter so far.
See the live data behind this article on ORTEX.
Open BKSY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.